tirzepatide news - Search News

INSIDER on MSN · 1d

The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.

FOX News on MSN · 19h

FDA approves first medication for obstructive sleep apnea — which also promotes weight loss

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

healthday · 59m

FDA Approves Generic GLP-1 Medicine For Diabetes Treatment

The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a

Obesity Drug Zepbound Approved for Obstructive Sleep Apnea

The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to severe OSA in people with obesity.

Health and Me on MSN · 2d

This Popular Weight Loss Drug Can Now Be Used To Treat Sleep Apnea

Zepbound is the first medication approved to treat people with obstructive sleep apnea, said Sailly Seymor, director of FDA's division of pulmonology, allergy, and critical care.

7h

‘An insatiable itch’: Why some people are turning to weight-loss medications to help quiet food noise

Savannah Mendoza used to spend most of her paychecks on food delivery apps and at fast food drive-thrus, trying to satisfy a ...

6don MSN

FDA says shortage of GLP-1 drug tirzepatide is over

The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...

7hon MSN

Elon Musk Shares Christmas Weight-Loss Post: 'Ozempic Santa'

Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of ...

1d

Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher prices

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 501.82% and ...

MedPage Today6d

FDA Says Compounded Tirzepatide Must Exit the Market

Approved in 2022 for type 2 diabetes and in 2023 for chronic weight management along with diet and exercise, tirzepatide is ...

FDA confirms shortage of weight loss drug tirzepatide is over, gives compounders a grace period

The FDA on Thursday confirmed that a shortage of Eli Lilly’s obesity drug tirzepatide has been resolved, a move that will put ...

2don MSN

FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.

1d

Hold Rating on Inspire Medical Systems Amid FDA Approval of Tirzepatide for OSA

Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on December 9.Don't Miss Our ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results